$89.99
This item has been third-party tested by accredited U.S. laboratories and confirmed to meet a minimum purity of 98% through rigorous verification standards.
Updated COA's
Secure Shipping Guaranteed
Verified for Purity
$89.99
Research Chemical products are third-party tested by MZ Biolabs, an independent laboratory based in Arizona. Each batch is analyzed to ensure accuracy, purity, and that all specifications are met.
A synthetic peptide hormone, CJC-1295 + DAC, or more commonly known as CJC 1295, is a GHRH analog that can induce the secretion of growth hormones in controlled laboratory settings.
What makes this compound stand out from other peptides is its ability to bind to albumin after administration. This results in an extended half-life, along with a longer duration of action, compared to traditional GHRH peptides – making it highly effective over prolonged periods.
Crafted as a synthetic analog to growth hormone-releasing factor (GRF), CJC-1295 DAC is designed for controlled stimulation of human growth hormone (HGH) release.
This peptide is composed of four amino acids arranged in a specific sequence, enhancing its biological activity and stability.
‘DAC’ stands for Drug Affinity Complex within the context of CJC 1295 DAC. The inclusion extends the half-life by allowing it to stay active longer than naturally occurring GRF.
This extended duration stems from CJC-1295 DAC’s ability to bind with serum albumin post-administration and slowly release over time – making it attractive for long-term studies requiring sustained HGH simulation.
A key property underpinning why CJC-1295 works effectively in lab studies thus far is its resistance to enzymatic degradation or breakdown inside test subjects, attributed mainly to its unique structure, including the DAC component.
In clinical research involving CJC-1295, an increase in plasma growth hormone levels was observed until approximately week two after injection, demonstrating the effectiveness of this compound in investigating hormonal regulation processes in animal studies.
An interesting feature about CJC-1295 is its ability to preserve normal physiologic release, making it an exciting subject matter within endocrinology-related experiments where maintaining hormonal balance remains critical.
In another intriguing investigation, it was discovered that adding DAC can potentially influence longevity-related biological processes, which makes it crucial for future aging studies.
By purchasing from ResearchChemical.com, you acknowledge and agree that you are acquiring Research Chemicals. These chemical substances are specifically designed for utilization in scientific and medical research endeavors.
It is important to note that these research chemicals are exclusively intended for laboratory use. They are not sold for consumer use.
Please be advised that the statements made on this website have not been evaluated by the U.S. Food and Drug Administration (FDA). Furthermore, the products offered by this company are not intended to diagnose, treat, cure, or prevent any disease.
The information provided on this website is solely for informational and educational purposes and should not be considered as medical advice or a substitute for professional medical guidance.
ResearchChemical.com, its manufacturers, sellers, and distributors hold no liability for any consequences arising from the misuse, improper handling, or usage of these chemicals.
Please be aware that the sale and purchase of these chemicals may be subject to legal restrictions and regulations in some jurisdictions. It is the buyer’s responsibility to ensure compliance with all applicable laws and regulations.
1. Timms, M., Ganio, K., Forbes, G., Bailey, S., & Steel, R. (2019). An immuno polymerase chain reaction screen for the detection of CJC‐1295 and other growth‐hormone‐releasing hormone analogs in equine plasma. Drug testing and analysis, 11(6), 804-812
2. Teichman, S. L., Neale, A., Lawrence, B., Gagnon, C., Castaigne, J. P., & Frohman, L. A. (2006). Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. The Journal of Clinical Endocrinology & Metabolism, 91(3), 799-805.
3. Sackmann-Sala, L., Ding, J., Frohman, L. A., & Kopchick, J. J. (2009). Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects. Growth Hormone & IGF Research, 19(6), 471-477.
4. Ionescu, M., & Frohman, L. A. (2006). Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. The Journal of Clinical Endocrinology & Metabolism, 91(12), 4792-4797.
5. Pinyot, A., Nikolovski, Z., Bosch, J., Such-Sanmartín, G., Kageyama, S., Segura, J., & Gutiérrez-Gallego, R. (2012). Growth hormone secretagogues: out of competition. Analytical and bioanalytical chemistry, 402, 1101-1108.
6. Campbell, R. M., Bongers, J., & Felix, A. M. (1995). Rational design, synthesis, and biological evaluation of novel growth hormone releasing factor analogues. Biopolymers: Original Research on Biomolecules, 37(2), 67-88.
7. Campbell, R. M., Stricker, P., Miller, R., Bongers, J., Liu, W., Lambros, T., … & Heimer, E. P. (1994). Enhanced stability and potency of novel growth hormone-releasing factor (GRF) analogues derived from rodent and human GRF sequences. Peptides, 15(3), 489-495.
8. Teichman SL, et al. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. The Journal of Clinical Endocrinology & Metabolism. 2006;91(3):799-805. doi: 10.1210/jc.2005-1536.
9. Ionescu, M., & Frohman, L. A. (2006). Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. The Journal of Clinical Endocrinology & Metabolism, 91(12), 4792-4797.
10. Ma, X., Lin, L., Yue, J., Pradhan, G., Qin, G., Minze, L. J., … & Sun, Y. (2013). Ghrelin receptor regulates HFCS-induced adipose inflammation and insulin resistance. Nutrition & diabetes, 3(12), e99-e99.
Please note that the above references provide evidence for the potential benefits of CJC 1295 DAC Peptide as stated in the product description. For more in-depth information, kindly refer to these scholarly works.
CJC-1295 is a growth hormone secretagogue that stimulates the release of growth hormone from the anterior pituitary. Growth Hormone promotes increased growth hormone levels, muscle growth, and bone density.
CJC-1295 is generally well-tolerated in healthy subjects and has shown a favorable safety profile in clinical trials with minimal adverse reactions.
DAC, which stands for Drug Affinity Complex, is an added chemical compound in CJC-1295 DAC, allowing for prolonged stimulation of growth hormone release. This modification extends the peptide’s half-life and enables continuous stimulation of growth hormone secretion.
Ipamorelin and CJC-1295 are both growth hormone secretagogues that stimulate the release of growth hormone from the pituitary gland. They work synergistically to increase growth hormone levels. Additionally, their combination has shown potential in promoting longevity and overall well-being by positively influencing growth hormone secretion and insulin-like growth factor levels in recent laboratory research.
If you are searching for where to buy CJC 1295 DAC online, you will come across many options. Several companies offer peptides, but unfortunately, not all prioritize quality assurance.
Research Chemical stands out in this landscape. We’re committed to delivering only the finest CJC 1295 for sale online. When you decide to buy peptides from us, rest assured, you’re opting for top-tier quality.
Our high quality peptides for sale undergo rigorous testing, verified by esteemed American third-party laboratories—labs that welcome phone or email inquiries to confirm their certificate’s authenticity. Our peptides are preserved in lyophilized form inside glass containers and maintained in cool conditions to uphold their potency.
You can trust in our assortment of top-grade research chemicals, all backed by a reassuring 60-day money-back guarantee. Plus, enjoy free shipping for orders over $149, with expedited shipping options available. Subscribers to our newsletter enjoy a 10% discount, and choosing cryptocurrency for payment affords an additional 10% off.
Choose Research Chemical, and you’re not just selecting a seller; you’re opting for verified excellence, secured packaging, prompt deliveries, and exemplary customer service. For any queries about our CJC 1295 DAC for sale or any other product, don’t hesitate to contact us. We’re here to assist promptly.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
What makes this compound stand out from other peptides is its ability to bind to albumin after administration. This results in an extended half-life, along with a longer duration of action, compared to traditional GHRH peptides – making it highly effective over prolonged periods.
Crafted as a synthetic analog to growth hormone-releasing factor (GRF), CJC-1295 DAC is designed for controlled stimulation of human growth hormone (HGH) release.
This peptide is composed of four amino acids arranged in a specific sequence, enhancing its biological activity and stability.
‘DAC’ stands for Drug Affinity Complex within the context of CJC 1295 DAC. The inclusion extends the half-life by allowing it to stay active longer than naturally occurring GRF.
This extended duration stems from CJC-1295 DAC’s ability to bind with serum albumin post-administration and slowly release over time – making it attractive for long-term studies requiring sustained HGH simulation.
A key property underpinning why CJC-1295 works effectively in lab studies thus far is its resistance to enzymatic degradation or breakdown inside test subjects, attributed mainly to its unique structure, including the DAC component.
In clinical research involving CJC-1295, an increase in plasma growth hormone levels was observed until approximately week two after injection, demonstrating the effectiveness of this compound in investigating hormonal regulation processes in animal studies.
An interesting feature about CJC-1295 is its ability to preserve normal physiologic release, making it an exciting subject matter within endocrinology-related experiments where maintaining hormonal balance remains critical.
In another intriguing investigation, it was discovered that adding DAC can potentially influence longevity-related biological processes, which makes it crucial for future aging studies.
By purchasing from ResearchChemical.com, you acknowledge and agree that you are acquiring Research Chemicals. These chemical substances are specifically designed for utilization in scientific and medical research endeavors.
It is important to note that these research chemicals are exclusively intended for laboratory use. They are not sold for consumer use.
Please be advised that the statements made on this website have not been evaluated by the U.S. Food and Drug Administration (FDA). Furthermore, the products offered by this company are not intended to diagnose, treat, cure, or prevent any disease.
The information provided on this website is solely for informational and educational purposes and should not be considered as medical advice or a substitute for professional medical guidance.
ResearchChemical.com, its manufacturers, sellers, and distributors hold no liability for any consequences arising from the misuse, improper handling, or usage of these chemicals.
Please be aware that the sale and purchase of these chemicals may be subject to legal restrictions and regulations in some jurisdictions. It is the buyer’s responsibility to ensure compliance with all applicable laws and regulations.
1. Timms, M., Ganio, K., Forbes, G., Bailey, S., & Steel, R. (2019). An immuno polymerase chain reaction screen for the detection of CJC‐1295 and other growth‐hormone‐releasing hormone analogs in equine plasma. Drug testing and analysis, 11(6), 804-812
2. Teichman, S. L., Neale, A., Lawrence, B., Gagnon, C., Castaigne, J. P., & Frohman, L. A. (2006). Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. The Journal of Clinical Endocrinology & Metabolism, 91(3), 799-805.
3. Sackmann-Sala, L., Ding, J., Frohman, L. A., & Kopchick, J. J. (2009). Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects. Growth Hormone & IGF Research, 19(6), 471-477.
4. Ionescu, M., & Frohman, L. A. (2006). Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. The Journal of Clinical Endocrinology & Metabolism, 91(12), 4792-4797.
5. Pinyot, A., Nikolovski, Z., Bosch, J., Such-Sanmartín, G., Kageyama, S., Segura, J., & Gutiérrez-Gallego, R. (2012). Growth hormone secretagogues: out of competition. Analytical and bioanalytical chemistry, 402, 1101-1108.
6. Campbell, R. M., Bongers, J., & Felix, A. M. (1995). Rational design, synthesis, and biological evaluation of novel growth hormone releasing factor analogues. Biopolymers: Original Research on Biomolecules, 37(2), 67-88.
7. Campbell, R. M., Stricker, P., Miller, R., Bongers, J., Liu, W., Lambros, T., … & Heimer, E. P. (1994). Enhanced stability and potency of novel growth hormone-releasing factor (GRF) analogues derived from rodent and human GRF sequences. Peptides, 15(3), 489-495.
8. Teichman SL, et al. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. The Journal of Clinical Endocrinology & Metabolism. 2006;91(3):799-805. doi: 10.1210/jc.2005-1536.
9. Ionescu, M., & Frohman, L. A. (2006). Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. The Journal of Clinical Endocrinology & Metabolism, 91(12), 4792-4797.
10. Ma, X., Lin, L., Yue, J., Pradhan, G., Qin, G., Minze, L. J., … & Sun, Y. (2013). Ghrelin receptor regulates HFCS-induced adipose inflammation and insulin resistance. Nutrition & diabetes, 3(12), e99-e99.
Please note that the above references provide evidence for the potential benefits of CJC 1295 DAC Peptide as stated in the product description. For more in-depth information, kindly refer to these scholarly works.
Join our insider list for the latest research insights, product releases, and special offers—delivered straight to your inbox.
